Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Gynecological”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableUnknownNCT00601406
What this trial is testing

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer

Who this might be right for
Breast CancerCervical CancerEndometrial Cancer+7 more
The Christie NHS Foundation Trust 2,200
Testing effectiveness (Phase 2)UnknownNCT04699071
What this trial is testing

Trial of Lenvatinib Plus PembrolizumAb in Recurrent Gynecological Clear Cell Adenocarcinomas (LARA)

Who this might be right for
AdenocarcinomasRecurrent Gynecological
National University Hospital, Singapore 10
Large-scale testing (Phase 3)Study completedNCT02855944
What this trial is testing

ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 349
Testing effectiveness (Phase 2)UnknownNCT03827837
What this trial is testing

Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCervical Cancer+2 more
Jiangsu HengRui Medicine Co., Ltd. 265
Testing effectiveness (Phase 2)UnknownNCT05028504
What this trial is testing

A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer

Who this might be right for
Gynecological Cancer
Sichuan Cancer Hospital and Research Institute 86
Testing effectiveness (Phase 2)Looking for participantsNCT06798207
What this trial is testing

A Clinical Trial of TQB2102 for Injection in Gynecological Tumors With Recurrent/Metastatic Advanced

Who this might be right for
Gynecological Tumors
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 170
Early research (Phase 1)Study completedNCT00770536
What this trial is testing

AMG386 Comb w. Either Pegylated Liposomal Doxorubicin or Topotecan Subjects w. Advanced Recurrent Epithelial Ovarian CR

Who this might be right for
CancerCarcinomaFallopian Tube Cancer+6 more
Amgen 103
Not applicableEnrolling By InvitationNCT07594327
What this trial is testing

Quality of Life and Sexuality After Pelvic Exenteration for Gynecologic Cancer

Who this might be right for
Cervical CancersVaginal CancersVulvar Cancers+2 more
Tampere University Hospital 21
Testing effectiveness (Phase 2)Study completedNCT01891344
What this trial is testing

Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2)

Who this might be right for
Ovarian CancerEpithelial Ovarian CancerFallopian Tube Cancer+1 more
pharmaand GmbH 491
Early research (Phase 1)UnknownNCT05475847
What this trial is testing

Study of C-TIL052A Cell Therapy in Advanced Cervical Cancer

Who this might be right for
Cervical Cancer
Fudan University 20
Not applicableStudy completedNCT03270995
What this trial is testing

Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsEndometrial Neoplasms+1 more
McGill University 144
Testing effectiveness (Phase 2)Ended earlyNCT01184053
What this trial is testing

Trisenox® in Women With Metastatic Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
UNC Lineberger Comprehensive Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06131450
What this trial is testing

BL-M07D1 in Patients With HER2-expressing Recurrent or Metastatic Gynecologic Malignancies

Who this might be right for
Gynecological Malignancies
Sichuan Baili Pharmaceutical Co., Ltd. 138
Testing effectiveness (Phase 2)Looking for participantsNCT06023862
What this trial is testing

A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study)

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+3 more
Yonsei University 198
Testing effectiveness (Phase 2)Looking for participantsNCT05512208
What this trial is testing

Avutometinib (VS-6766) Plus Defactinib

Who this might be right for
Endometrioid CancerMucinous Ovarian CancerHigh Grade Serous Ovarian Cancer+2 more
University of Oklahoma 55
Testing effectiveness (Phase 2)Looking for participantsNCT05803018
What this trial is testing

BL-B01D1 in Patients With Multiple Solid Tumors, Including Recurrent or Metastatic Gynecological Malignancies

Who this might be right for
Gynecological Malignant TumorSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 38
Testing effectiveness (Phase 2)Study completedNCT01482715
What this trial is testing

Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II)

Who this might be right for
Ovarian CancerFallopian Tube CancerPeritoneal Cancer+1 more
pharmaand GmbH 136
Early research (Phase 1)UnknownNCT05238818
What this trial is testing

Single Arm Phase I Trail of Autologous Tumor Infiltrating Lymphocyte Injection (GT202) in the Treatment of Metastatic or Recurrent Gynecological Tumors

Who this might be right for
Metastatic or Recurrent Gynecological Tumors
XinWu 36
Post-approval studies (Phase 4)UnknownNCT04035785
What this trial is testing

A Clinical Study on Kangfu Anti-inflammatory Suppository of Gynaecology Combined With Antibiotics for Pelvic Inflammatory Diseases (Evidence of Dampness and Heat Accumulation)

Who this might be right for
Pelvic Inflammatory Diseases
China Academy of Chinese Medical Sciences 240
Early research (Phase 1)Study completedNCT00268918
What this trial is testing

Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer+3 more
Dana-Farber Cancer Institute 24
Load More Results